RNA
|Avidity Biosciences Inc
NASDAQ
USD 30.97
-0.01|-0.03%
Current Price
USD 30.97
Change
USD -0.01 (-0.03%)
P/E Ratio
Dividend Yield
Market Cap
3.72B
Volume
81,383
Open
USD 31.40
Previous Close
USD 30.98
52-Week High
USD 56.00
52-Week Low
USD 21.51
About Avidity Biosciences Inc
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the delivery of RNA therapeutics called antibody oligonucleotide conjugates (AOCs). Its AOC platform is designed to combine the specificity of monoclonal antibodies with the precision of RNA therapeutics to target the root cause of diseases previously untreatable with such therapeutics. The company's pipeline has three programs in registrational clinical trials, such as Delpacibart etedesiran, which is in Phase 3 development stag...
Sector:Healthcare
Industry:Biotechnology
CEO:Ms. Sarah Boyce
Employees:391
Headquarters:San Diego, USA
Website:www.aviditybiosciences.com
Dividend History
Dividend Payments
| Declared Date | Record Date | Payment Date | Amount | Frequency |
|---|
Similar Companies
Explore Stocks by Sector
technology
finance
healthcare
Frequently Asked Questions